Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones

Benova, A., Ferencakova, M., Bardova, K., Funda, J., Prochazka, J., Spoutil, F., Cajka, T., Dzubanova, M., Balcaen, T., Kerckhofs, G., Willekens, W., van Lenthe, G. H., Alquicer, G., Pecinova, A., Mracek, T., Horakova, O., Rossmeisl, M., Kopecky, J., & Tencerova, M. (2022). Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones. Molecular Metabolism, 65, 101598. https://doi.org/10.1016/j.molmet.2022.101598 (Original work published 2022)